baber/WOPTO huggingface dataset:
Patent NZ-521412-A (NZ)
Title: DNA sequence obtained from cestrum yellow leaf curling virus (CmYLCV) comprising a full length transcript promoter region
Inventor: HOHN THOMAS
IPC: C12N15/82
Filed: 2001-03-26
Abstract: Described are DNA sequences that function as promoters of transcription of associated nucleotide sequences. More specifically, the DNA sequences described confer constitutive expression to an associated nucleotide sequence in addition to recombinant sequences containing the promoter sequences. The recombinant DNA sequences may be used to create transgenic plants, but especially plants expressing a nucleotide sequence of interest at all times and in most tissues and organs.
Patent NZ-522960-A (NZ)
Title: Factor VIIA inhibitory (thio)urea derivatives, their preparation and their use
Inventor: KLINGLER OTMAR
IPC: C07D319/18
Filed: 2001-05-26
Abstract: The present invention relates to compounds of the formula I, in which: R1 is selected from hydrogen, hydroxy, (C1-C12)-alkoxycarbonyl-, (C6-C14)-aryl-(C1-C4)-alkoxycarbonyl- and (C6-C14)-aryloxycarbonyl-, where each of the aryl groups is unsubstituted or substituted by one or more identical or different substituents selected from (C1-C12)-alkyl, halogen and (C1-C12)-alkoxy; R2 is selected from hydrogen, (C1-C12)-alkyl, (C6-C14)-aryl, (C6-C14)-aryl-(C1-C4)-alkyl-, R20-( C1-C12)-alkyl-, R20-( C6-C14)-aryl- and R20-( C6-C14)-aryl-(C1-C4)-alkyl-, where R20is selected from hydroxycarbonyl-, (C1-C12)-alkoxycarbonyl- and (C6-C14)-aryl-(C1-C4)-alkoxycarbonyl-; R3 is selected from hydrogen, cyano, hydroxy and (C1-C12)-alkyl; R4 is selected from (C1-C12)-alkyl, (C6-C14)-aryl, (C6-C14)-aryl-(C1-C4)-alkyl-, Het and Het-(C1-C4)-alkyl-, where the alkyl, aryl and Het groups are unsubstituted or substituted by one or more identical or different substituents R10; R5, is selected from hydrogen, (C1-C12)-alkyl, (C6-C14)-aryl, (C6-C14)-aryl-(C1-C4)-alkyl-, Het, Het-(C1-C4)-alkyl-, (C6-C14)-aryl-(C1-C4)-alkyl-aminocarbonyl- and Het-(C1-C4)-alkyl-aminocarbonyl-, where the alkyl, aryl and Het groups are unsubstituted or substituted by one or more identical or different substituents R10; or R4 and R5 together with the carbon atom to which they are bonded form a saturated or unsaturated 3-membered to 8-membered ring which is a carbocyclic ring or a heterocyclic ring containing 1, 2 or 3 identical or different ring heteroatoms selected from nitrogen, oxygen and sulfur, and which can be condensed to one or two saturated or unsaturated carbocyclic ring systems or heterocyclic ring systems containing 5 to 10 ring atoms of which 1, 2 or 3 can be identical or different ring heteroatoms selected from nitrogen, oxygen and sulfur, where the resulting R4(R5)C group is unsubstituted or substituted by 1 or more identical or different substituents R10; R6 is selected from hydrogen, hydroxy, (C1-C8)-alkoxy, (C6-C14)-aryl-(C1-C4)-alkoxy-; A is halogen; X is sulphur or oxygen; m is 0-4 and n is 0-3. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of thromboembolic diseases and restenoses. They are reversible inhibitors of the blood clotting enzyme factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
Patent NZ-526559-A (NZ)
Title: Anti-loading treatments for coated or composite abrasives
Inventor: SWEI GWO SHIN
IPC: B24D3/00
Filed: 2001-12-28
Abstract: Disclosed herein is an abrasive oversized with a layer consisting essentially of (a) thermoplastic or thermoset resin; and (b) an inorganic anti-loading agent selected from the group consisting of metal silicates, silica, metal carbonates, and metal sulfates, wherein the metal silicates can be selected from the group consisting of magnesium silicates, potassium aluminum silicates, aluminum silicates, and calcium silicates; the magnesium silicates include talc; the potassium aluminum silicates include micas; the aluminum silicates include clays; the calcium silicates include wollastonite; the silica can be selected from the group consisting of fused silica, fumed silica, and precipitated amorphous silica; the metal carbonates can include calcium carbonate; and the metal sulfates can include hydrous calcium sulfate or anhydrous calcium sulfate.
Patent NZ-529142-A (NZ)
Title: Alkyl and/or acyl polyglycerols, which provide increased permeability of biological membranes
Inventor: EIBL HANSJORG
IPC: A61K47/10
Filed: 2002-05-13
Abstract: A pharmaceutical preparation is described that enhances penetration of active substances through the tissue membrane or barrier, for example, the blood brain barrier or of a target organ such as the liver, skin etc.
Patent NZ-531546-A (NZ)
Title: Aluminium electrowinning cells with sloping foraminate oxygen-evolving anodes
Inventor: DE NORA VITTORIO
IPC: C25C3/12
Filed: 2002-08-29
Abstract: Disclosed is a cell for the electrowinning of aluminium from alumina, comprising an inclined plate-like or grid-like open anode structure which has a generally v-shaped configuration in cross-section and which has a downwardly-oriented sloping electrochemically active surface that is generally v-shaped in cross-section and spaced above an upwardly-oriented corresponding sloping cathode surface by an anode-cathode gap in which alumina dissolved in a circulating electrolyte is electrolysed, the generally v-shaped plate-like or grid-like open anode structure having a plurality of anode through-passages distributed thereover for an up-flow of alumina-depleted electrolyte from the anode-cathode gap, characterised in that one or more electrolyte guide members located above the generally v-shaped plate-like or grid-like open anode structure is/are arranged to guide substantially all the up-flowing alumina-depleted electrolyte to an alumina feeding area where it is enriched with alumina and then over and around an upper end of the generally v-shaped plate-like or grid-like anode structure from where alumina- enriched electrolyte is fed into the anode-cathode gap. Also disclosed is a method for electrowinning aluminium from alumina in the above cell.
Patent NZ-540574-A (NZ)
Title: Substituted thiazolopyrimidines used as analgesics
Inventor: GERLACH MATTHIAS
IPC: A61P25/20
Filed: 2002-03-13
Abstract: Disclosed herein are substituted thiazolopyrimidines having general structure (II), wherein the substituents for the variables shown in the structure are as defined in the specification, a method for their production, substance libraries containing these compounds, pharmaceutical compositions containing these compounds, medicaments containing these compounds, the use of these compounds in the production of medicaments for treating pain, epilepsy, schizophrenia, neurodegenerative diseases, in particular Alzheimer's disease, Huntington's disease and Parkinson's disease, for treating cerebral ischaemia and infarcts, psychosis caused by increased amino acid levels, cerebral oedema, insufficiency states of the central nervous system, in particular in hypoxia, especially newborn hypoxia and anoxia, for treating AIDS-related dementia, encephalomyelitis, Tourette's syndrome, perinatal asphyxia, tinnitus, neuropathic pain, diseases of the respiratory tract, cancer, cardiac arrythmia, immune disorders and diseases, inflammatory conditions and diseases, renal shutdown, dyssomnia, strokes, thromboses, urinary incontinence, diabetes, psoriasis, septicaemic shock, cerebral traumas, glaucoma and/or congestive heart failure. (62) Divided Out of 528639
Patent NZ-541906-A (NZ)
Title: Identity card with two core layers fused together including accommodation for microchip and antenna
Inventor: BUURSMA CORNELIS
IPC: B42D15/10
Filed: 2004-02-24
Abstract: An identity card containing a microchip that can be used in a travel document or as a separate card is disclosed. This identity card consists of at least two core layers 6, 7, preferably of polycarbonate material, that are fused to one another. In each of the core layers there is a recess 12, 13, each of a different size. On assembly these recesses become situated on top of one another and a semiconductor chip 14 is accommodated in the larger recess formed as a result. There is a covering layer 8 fused to at least one of the core layers whilst a layer that can be written on by laser has also been applied. There can be (semi-)transparent windows on top of one another in the core layer and if the covering layer is transparent light can be transmitted, it being possible to apply a specific pattern in the windows.
Patent NZ-542443-A (NZ)
Title: Wireless gateway providing data and protocol conversion via network service interfaces
Inventor: KIM DUK SAN
IPC: H04B7/185
Filed: 2004-03-22
Abstract: A wireless gateway comprises a local network interface using a local network interface protocol and a wireless interface providing access to multiple public network interface protocols. The gateway further has a controller and one or more service interfaces connected to the local network interface and to the wireless interface. The controller operates to detect a public network interface protocol currently in use from the multiple public network interface protocols accessible to the wireless interface. Each service interface provides automatic data conversion between the local network interface protocol and the detected public network interface protocol.
Patent NZ-556152-A (NZ)
Title: Substituted pteridines for treating inflammatory diseases
Inventor: MARTYRES DOMNIC
Filed: 2005-11-25
Abstract: Disclosed is a substituted pteridine derivative of formula 1, wherein R1 denotes a saturated or unsaturated, five-, six- or seven-membered heterocyclic ring which may contain a nitrogen atom and another atom selected from among nitrogen, sulphur and oxygen; R2 denotes a five-, six- or seven-membered heterocyclic ring which may contain a nitrogen atom and another atom selected from among nitrogen, sulphur and oxygen; and R3 denotes a group of formula 1a, wherein A denotes a monocyclic heterocyclic ring or a bicyclic ring which contains one or more heteroatoms; X denotes NR3.2, O, S; Y denotes C1-4-alkylene, substituted by one or more R3.3; m denotes 0, 1, 2; R3.1 each independently of one another denote C1-4-alkyl, aryl, COOR3.1.1, CONR3.1.1R3.1.2, CN, NR3.1.1R3.1.2, NHCOR3.1.1, OR3.1.1, O-C1-4-haloalkyl, SO2R3.1.1, SO2NH2, halogen, C1-6-haloalkyl, C1-6-alkyl-CONH2, O-C1-6-alkyl-NH2, O-C3-6-cycloalkyl, O-C1-4-alkylene-C3-6-cycloalkyl; R3.1.1 denotes H, C1-4-alkyl; R3.1.2 denotes H, C1-4-alkyl; or R3.1 together with two atoms of A forms a 5- or 6-membered carbocyclic ring or a 5- or 6-membered heterocyclic ring which may contain one or more oxygen or nitrogen atoms; R3.2 denotes H, C1-6-alkyl; R3.3 each independently of one another denote C1-6-alkyl, C1-6-alkyl-OH, C3-6-cycloalkyl, C3-6-cycloalkyl-OH, O-C1-6-alkyl, COOH, COO-C1-6-alkyl, CONH2; or R3.3 together with one or two carbon atoms of Y forms a carbocyclic ring with 3, 4, 5 or 6 carbon atoms, or a pharmacologically acceptable salt, diastereomer, enantiomer, racemate, hydrate or solvate thereof. Also disclosed is the use of a compound of formula 1 for preparing a medicament for the treatment of diseases which can be treated by inhibiting the PDE4 enzyme. The use of a compound of formula 1 for treating a range of diseases which include respiratory or gastrointestinal complaints (including inflammatory diseases of the gastrointestinal tract); inflammatory diseases of the joints, skin or eyes; cancer (selected from acute and chronic leukaemia, acute lymphatic and acute myeloid leukaemia, and chronic lymphatic and chronic myeloid leukaemia), a bone tumour (such as an osteosarcoma) and all types of glioma (such as oligodendroglioma or glioblastoma); diseases of the peripheral or central nervous system (such as depression, bipolar or manic depression, acute and chronic anxiety states, schizophrenia, Alzheimer's disease, Parkinson's disease, and acute and chronic multiple sclerosis) or acute and chronic pain as well as injuries to the brain caused by stroke, hypoxia or craniocerebral trauma; respiratory or pulmonary diseases which are accompanied by increased mucus production; inflammation and/or obstructive diseases of the airways (such as COPD, chronic sinusitis, asthma, Crohn's disease, and ulcerative colitis) is further disclosed.
Patent NZ-556677-A (NZ)
Title: Quadrupled animal harness
Inventor: FORSTER TIMOTHY WILLIAM
IPC: A01K15/02
Filed: 2007-07-24
Abstract: A quadruped animal harness (10) has a back pad (12) adapted to be supported at a predetermined position on the back of the quadruped animal. There is also a rump strap (14) connected to a rear end of the pad and adapted to extend around the rump of the quadruped animal, a chest strap (16) connected to a front end of the pad and adapted to extend around the chest of the quadruped animal, a girth strap (18) connected to opposed sides of the pad and adapted to extend around the girth of the quadruped animal, and a connector strap (20) interconnecting the chest strap to the girth strap. A handle (22) is connected to the back pad. In use, the back pad is maintained at the predetermined position by the arrangement of the straps so as to enable a person to control and manipulate the quadruped animal when gripping the handle.
Patent NZ-560282-A (NZ)
Title: A valve that is activated to reduce flow through a solar collector when the temperature of the fluid is too high
Inventor: LAWSON DAVID
IPC: F16K3/26
Filed: 2006-06-29
Abstract: A method to protect a solar water heating system (10) from an over temperature event. The solar water heating system (10) has a collector (12) to heat water and a storage tank (14) for holding the heated water. In normal operation water is circulated around the system using thermo-siphoning until a desired temperature is reached, at which time circulation is stopped by a temperature controlled valve (30) closing. In some circumstances though, this can lead to a damaging heat build-up in the water in the collector (12). To help prevent this heat build-up a small fluid bypass is built into the valve (30). This reduced flow is able to use the losses associated with the collector (12) to reduce the maximum temperature of the water in the collector. In particular, the system is suitable for collector panels with a 1st order panel loss at or greater than 3-5 watt/m2/°C. To avoid noise problems associated with boiling of the heat exchange fluid, it is desirable to have a 1st order panel loss greater than 3.5 watt/m2/°C and ensure that the system pressure is higher than 1.7 bar gauge.
Patent NZ-561459-A (NZ)
Title: Communication link termination indication signal method and apparatus
Inventor: MUIR BROCKETT
IPC: H04B7/00
Filed: 2006-02-17
Abstract: A method for indicating termination of a wireless communication link is disclosed. The method includes: providing at a wireless communication device multiple available candidate unique user selectable corresponding signals; determining whenever a wireless communication link for the wireless communication device has terminated either intentionally or unintentionally and without another specific positive indication to an end user of the wireless communication device; in response to determining that the wireless communication link has terminated, generating at the wireless communication device a unique user selected corresponding signal at the wireless communication device by selecting the unique user selected corresponding signal from available candidate unique user selectable corresponding signals to indicate termination of the wireless communication link, where the signal comprises at least one of musical content and spoken content.
Patent NZ-564579-A (NZ)
Title: Electric motor
Inventor: JOHNSON MICHAEL FREDERICK
IPC: H02P25/02
Filed: 2005-07-06
Abstract: An electric motor is disclosed which includes a stator, a salient pole rotor, and a control means. The stator has at least two stator windings arranged to form stator phases. The salient pole rotor located within the stator is separated from the stator by an air gap, the rotor being shaped and configured to define a higher and a lower magnetic reluctance path through the gap between the rotor and stator. The rotor further includes a field winding about the salient poles of the rotor, which field winding being configured to form a pole pair, and the field winding terminates in a selective electrical switch which determines the electrical continuity of the field winding so that a reverse voltage bias imposed across the switch results in the field winding being open circuit. The control circuit is configured to regulate the magnetizing of the field winding, and the control means is configured to regulate the production of torque in the motor by applying a voltage to another stator phase not responsible for energizing the field winding, at that moment in time, so that, at any given moment, one stator phase is usable for magnetizing the field winding whilst another phase or phases is/are responsible for torque production. In rotation, all stator phases alternate in the function of producing torque and regulating the magnetization of the rotor field winding.
Patent NZ-570619-A (NZ)
Title: Capsaicin and associated products added to animal feed for increased productivity in animals
Inventor: BLOCK STEPHANIE S
IPC: A23K1/16
Filed: 2007-03-09
Abstract: A method for feeding a non-avian monogastric animal is disclosed, wherein the method comprises: mixing a coated or encapsulated capsaicin product with an animal feed product selected from the group consisting of feed matter, a mineral, a vitamin, an amino acid, an antibiotic, a plant extract, a plant botanical, and combinations of any thereof, thus producing an animal feed composition or an animal feed supplement; and feeding the animal feed composition or the animal feed supplement to the non-avian monogastric animal wherein the non-avian monogastric animal is selected from the group consisting of swine, porcines, felines, canines, and rabbits.
Patent NZ-570730-A (NZ)
Title: The use of deferiprone and methods to treat and/or prevent Friedreich ataxia resulting from intracellular mishandling of iron
Inventor: MUNNICH ARNOLD
IPC: A61K31/4196
Filed: 2007-02-21
Abstract: 570730 Disclosed is the use of deferiprone, or a physiologically acceptable salt thereof, in the manufacture of a medicament to preferentially reduce or render inactive the toxic iron stores in the subcellular compartments of the brain; preferentially reduce or render inactive the toxic iron stores in the mitochondria for the prevention of mitochondrial iron-induced damage; preferentially reduce or render inactive the toxic iron stores in the mitochondria for the treatment of mitochondrial iron-induced damage or treatment of Friedreich ataxia resulting from mitochondrial iron-induced damage.
Patent NZ-574174-A (NZ)
Title: Resin anchor with a compressible envelope containing at least one sacheted curable product
Inventor: BUCQUET BARBARA
IPC: E04B1/48
Filed: 2007-07-11
Abstract: The resin anchor comprises an apertured tubular envelope designed to be compressed by a traction element, characterized in that it includes, on the inside of the envelope, a resin component and a hardener component that are intended to be mixed together and to cure under the action of the compression of the envelope (1), in order to fasten the anchor, at least one of the two components being sacheted, the mix formed from the two components being expelled out of the envelope via its apertures, during its compression. The traction element may be a screw that cooperates with the end element of the bushing CD forming a nut. The anchor is fastened both mechanically and chemically, for either solid material or hollow material.
Patent NZ-575359-A (NZ)
Title: Communition Apparatus with inner and outer comminution drums
Inventor: SHARP RODNEY WARWICK
IPC: B02C18/00
Filed: 2010-06-08
Abstract: Comminution apparatus 1 comprising an outer comminution drum 2 and at least one inner comminution drum 3, where the outer comminution drum 2 has a hollow portion and a longitudinal axis 6, and the inner comminution drum 3 has a longitudinal axis 5 and is positioned within the hollow portion of the outer comminution drum 2. The longitudinal axes of the drums are substantially parallel, but are not coaxial with each other. At least one of the drums is rotatable about its longitudinal axis. The inner comminution drum 3 has at least one projecting macerating feature 41 on its outer surface, and the outer comminution drum 2 has at least one projecting macerating feature 32 on its inner surface. During rotation of at least one of the outer comminution drum 2 or the inner comminution drum 3, about its longitudinal axis, the projecting macerating features come into close proximity but do not make contact, with each other.
Patent NZ-577017-A (NZ)
Title: Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
Inventor: CASTRO PALOMINO LARIA JULIO CESAR
IPC: C07D213/80
Filed: 2007-12-21
Abstract: Disclosed is a compound of formula (I) e.g. 2-(3-Fluoro-3'-methoxybiphenyl-4-ylamino)nicotinic acid wherein G1, G2, R1, R2, Ra, Rb, G3, G4 and M are defined in the specification and the pharmaceutically acceptable salts and N-oxides thereof for treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondilytis, multiple sclerosis, Wegener's granulomatosis, systemic lupus erythematosus, psoriasis and sarcoidosis.
Patent NZ-580755-A (NZ)
Title: Cross-species-specific cd3-epsilon binding domain
Inventor: KLINGER MATTHIAS
IPC: C07K16/10
Filed: 2008-04-03
Abstract: A polypeptide that is capable of binding to an epitope of human and Callithirix jacchus, Sanguinus oedipus or Saimiri sciureus CD3 epsilon chain. The epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs: 2, 4, 6 or 8 and comprises at least the amino acid sequence Gln-Asp-Gly-Asn-Glu. The polypeptide can be used as part of a dual variable binding domain antibody where the second binding domain binds to a cell surface tumour antigen selected from EGFRvIII, MCSP, carbonic anhydrase IX, CD30, CD33, CD44v6, EpCAM, MUC1, HBV and HCV
Patent NZ-582516-A (NZ)
Title: Piperidine compounds and uses thereof
Inventor: BASARAB GREGORY
IPC: C07D417/08
Filed: 2008-06-11
Abstract: Disclosed herein are piperidine derivatives of formula (Ia), wherein the substituents are as defined within the specification, processes for their preparation, pharmaceutical compositions containing said compounds as the active ingredient, their use as medicaments and their use in the manufacture of medicaments for the treatment of bacterial infections such as community-acquired pneumonia, hospital-acquired pneumonia, skin and skin structure infections, acute exacerbation of chronic bronchitis, acute sinusitis, acute otitis media, catheter-related sepsis, febrile neutropenia, osteomyelitis, endocarditis, urinary tract infections, Penicillin-resistant Streptococcus pneumonia, methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and Vancomycin-resistant Enterococci in warm-blooded animals such as humans.